EUVIMEDAvasta EUVIMED
Crossref

Lung transplantation from donation after circulatory death, evolution, and current status in the United States

Masashi Furukawa iD, Kentaro Noda iD, Ernest G Chan iD, John P Ryan, Jenalee N Coster, Pablo G Sanchez

Clinical Transplantation · 2023-03 · 37 (3)

DOI: 10.1111/ctr.14884 ↗

At a glance

Journal article in Clinical Transplantation, published online on 2023-01-02. Written by Masashi Furukawa and 5 co-authors. Institution: Division of Thoracic Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Major MEDLINE topics: Lung Transplantation, Tissue and Organ Procurement. Cited 33 times so far (Crossref); 29 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Background

The number of lung transplants from donors after circulatory death has increased over the last decade. This study aimed to describe the evolution and outcomes following lung transplantation donation after circulatory death (DCD) and report the practices and outcomes of ex vivo lung perfusion (EVLP) in this donor population.

Methods

This was a retrospective study using a prospectively collected national registry. The United Network for Organ Sharing (UNOS) database was queried to identify adult patients who underwent lung transplantation between May 1, 2005, and December 31, 2021. Kaplan–Meier analysis and Weibull regression were used to compare survival in four cohorts (donation after brain death [DBD] with or without EVLP, and DCD with or without EVLP). The primary outcome of interest was patient survival.

Results

Of the 21 356 recipients who underwent lung transplantation, 20 380 (95.4%) were from brain death donors and 976 (4.6%) from donors after circulatory death. Kaplan–Meier analysis showed no difference in the survival time between the two groups. In a multivariable analysis that controlled for baseline differences in donor and recipient characteristics, recipients who received lungs from cardiac death donors after EVLP had 28% shorter survival time relative to donor lungs after brain death without EVLP (hazard ratio [HR] 1.53, 95% confidence interval [CI] 1.10–2.15, p = .01).

Conclusions

The early survival differences observed after lung transplants from donors after circulatory death in lungs evaluated with EVLP deserves further investigation.

Subjects

MeSH terms (MEDLINE)

Lung TransplantationTissue and Organ ProcurementAdultHumansUnited StatesBrain DeathRetrospective StudiesLungTissue DonorsDeathGraft Survival

Author keywords

donation after circulatory death (DCD)donors and donationlung diseasepatient survival

Authors and institutions

  • Division of Thoracic Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

ORCID profiles: Masashi Furukawa, Kentaro Noda, Ernest G Chan

Cite

APA

Furukawa, M., Noda, K., Chan, E. G., Ryan, J. P., Coster, J. N., & Sanchez, P. G. (2023). Lung transplantation from donation after circulatory death, evolution, and current status in the United States. Clinical Transplantation, 37(3). https://doi.org/10.1111/ctr.14884

Vancouver

Furukawa M, Noda K, Chan EG, Ryan JP, Coster JN, Sanchez PG. Lung transplantation from donation after circulatory death, evolution, and current status in the United States. Clinical Transplantation. 2023;37(3). doi:10.1111/ctr.14884

BibTeX
@article{Furukawa2023,
  author = {Furukawa, Masashi and Noda, Kentaro and Chan, Ernest G and Ryan, John P and Coster, Jenalee N and Sanchez, Pablo G},
  title = {Lung transplantation from donation after circulatory death, evolution, and current status in the United States},
  journal = {Clinical Transplantation},
  year = {2023},
  volume = {37},
  number = {3},
  doi = {10.1111/ctr.14884}
}
Start for free →